1. Long-term estrogen replacement therapy prevents bone loss and fractures;Ettinger, B.; Genant, H.K.; Cann, C.E.;Ann Intern Med,1985
2. Calcitonin for prevention of postmenopausal bone loss;Maclntyre, I.; Stevenson, J.C.; Whitehead, M.I.; Wimalawansa, S.J.; Banks, L.M.; Healey, M.J.R.;Lancet,1988
3. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in postmenopausal osteoporosis;Storm, T.; Thamsborg, G.; Steiniche, T.; Genant, H.K.; Sorensen, O.H.;NEnglJ Med,1990
4. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis;Watts, N.B.; Harris, S.T.; Genant, H.K.; Wasnich, R.D.; Miller, P.D.; Jackson, R.D.;N EnglJMed,1990
5. Bone response to termination of nandrolone decanoate, 1-c vitamin D3 and calcium infusion treatment in';Geusens, P.; Dequeker, J.; Verstraeten, A.; Nijs, J.,1977